| 发明名称 |
QUINOLINE DERIVATIVE |
| 摘要 |
<p>Disclosed is a therapeutic or prophylactic agent showing good pharmacokinetics in vivo in the case of, for example, mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, digestive diseases, drug dependency, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-mediated diseases, alopecia or the like. Specifically disclosed is a qunoline derivative represented by general formula (1A) which has arginine-vasopressin 1b receptor antagonism, or a pharmaceutically acceptable salt of the same.</p> |
| 申请公布号 |
WO2011096461(A1) |
申请公布日期 |
2011.08.11 |
| 申请号 |
WO2011JP52210 |
申请日期 |
2011.02.03 |
| 申请人 |
TAISHO PHARMACEUTICAL CO., LTD.;KUWADA, TAKESHI;YOSHINAGA, MITSUKANE;NOZAWA, DAI;ISHIZAKA, TOMOKO;KASHIWA, SHUHEI;SHIROKAWA, SHINICHI;SHIMAZAKI, YOUICHI |
发明人 |
KUWADA, TAKESHI;YOSHINAGA, MITSUKANE;NOZAWA, DAI;ISHIZAKA, TOMOKO;KASHIWA, SHUHEI;SHIROKAWA, SHINICHI;SHIMAZAKI, YOUICHI |
| 分类号 |
C07D215/20;A61K31/46;A61K31/47;A61K31/4709;A61K31/496;A61K31/5377;A61K31/541;A61K31/55;A61K31/551;A61K31/553;A61P1/00;A61P3/04;A61P9/00;A61P9/10;A61P9/12;A61P17/02;A61P17/14;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P29/00;A61P37/00;C07D215/14;C07D401/04;C07D401/12;C07D401/14;C07D405/14;C07D413/12;C07D451/02;C07D451/06;C07D455/03;C07D471/04;C07D491/107 |
主分类号 |
C07D215/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
